Abstract
The S. pyogenes (Sp) Cas9 endonuclease is an important gene-editing tool. SpCas9 is directed to target sites based on complementarity to a complexed single-guide RNA (sgRNA). However, SpCas9-sgRNA also binds and cleaves genomic off-targets with only partial complementarity. To date, we lack the ability to predict cleavage and binding activity quantitatively, and rely on binary classification schemes to identify strong off-targets. We report a quantitative kinetic model that captures the SpCas9-mediated strand-replacement reaction in free-energy terms. The model predicts binding and cleavage activity as a function of time, target, and experimental conditions. Trained and validated on high-throughput bulk-biochemical data, our model predicts the intermediate R-loop state recently observed in single-molecule experiments, as well as the associated conversion rates. Finally, we show that our quantitative activity predictor can be reduced to a binary off-target classifier that outperforms the established state-of-the-art. Our approach is extensible, and can characterize any CRISPR-Cas nuclease – benchmarking natural and future high-fidelity variants against SpCas9; elucidating determinants of CRISPR fidelity; and revealing pathways to increased specificity and efficiency in engineered systems.
Original language | English |
---|---|
Article number | 1367 |
Pages (from-to) | 1-10 |
Number of pages | 10 |
Journal | Nature Communications |
Volume | 13 |
DOIs | |
Publication status | Published - 15 Mar 2022 |
Bibliographical note
Funding Information:We would like to thank Kristian Blom, Diewertje Dekker, and Sonny de Jong for valuable discussions and/or their help during the project. We also thank the members of the Chirlmin Joo lab and Stan Brouns lab for valuable discussions. We thank Evan Boyle for sharing data and answering all our questions. This work was supported by: Netherlands Organization for Scientific Research (NWO) (FOM-140), B.E.M.; Zwaartekracht NanoFront, NWO M.K.; Parents in KIND program, The Kavli Institute of Nanoscience Delft/the Department of Bionanoscience at TU Delft/through a Spinoza Prize awarded to M. Dogterom, M.D.; University of Texas College of Natural Sciences Catalyst award and the Welch Foundation (F-1808) I.J.F.; U.S. National Institute of Health (R01GM124141, F32AG053051) I.J.F. and S.K.J.
Publisher Copyright:
© 2022, The Author(s).
Funding
We would like to thank Kristian Blom, Diewertje Dekker, and Sonny de Jong for valuable discussions and/or their help during the project. We also thank the members of the Chirlmin Joo lab and Stan Brouns lab for valuable discussions. We thank Evan Boyle for sharing data and answering all our questions. This work was supported by: Netherlands Organization for Scientific Research (NWO) (FOM-140), B.E.M.; Zwaartekracht NanoFront, NWO M.K.; Parents in KIND program, The Kavli Institute of Nanoscience Delft/the Department of Bionanoscience at TU Delft/through a Spinoza Prize awarded to M. Dogterom, M.D.; University of Texas College of Natural Sciences Catalyst award and the Welch Foundation (F-1808) I.J.F.; U.S. National Institute of Health (R01GM124141, F32AG053051) I.J.F. and S.K.J.
Funders | Funder number |
---|---|
Kavli Institute of Nanoscience Delft/the Department of Bionanoscience | |
National Institutes of Health | R01GM124141 |
National Institute on Aging | F32AG053051 |
Welch Foundation | F-1808 |
College of Natural Sciences, University of Texas at Austin | |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | FOM-140 |